161 related articles for article (PubMed ID: 38018593)
1. A case report on clinical features, diagnosis, and treatment of rhino-orbito-cerebral mucormycosis.
Ding JQ; Xie Y
Immun Inflamm Dis; 2023 Nov; 11(11):e1080. PubMed ID: 38018593
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
3. Early suspicion can save lives; mucormycosis in two children with diabetic ketoacidosis in Pakistan.
Shahid A; Fatima B; Khan YN; Ibrahim MN; Raza J
J Pak Med Assoc; 2022 Apr; 72(4):790-792. PubMed ID: 35614628
[TBL] [Abstract][Full Text] [Related]
4. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.
Cag Y; Erdem H; Gunduz M; Komur S; Ankarali H; Ural S; Tasbakan M; Tattevin P; Tombak A; Ozturk-Engin D; Tartar AS; Batirel A; Tekin R; Duygu F; Caskurlu H; Kurtaran B; Durdu B; Haciseyitoglu D; Rello J;
Eur J Intern Med; 2022 Jun; 100():56-61. PubMed ID: 35304041
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
[TBL] [Abstract][Full Text] [Related]
7. Rhino-Orbito-Cerebral Mucormycosis in Diabetic Disease Mucormycosis in Diabetic Disease.
Galletti B; Freni F; Meduri A; Oliverio GW; Signorino GA; Perroni P; Galletti C; Aragona P; Galletti F
J Craniofac Surg; 2020 Jun; 31(4):e321-e324. PubMed ID: 32028364
[TBL] [Abstract][Full Text] [Related]
8. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
[TBL] [Abstract][Full Text] [Related]
10. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
11. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
13. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
Mitra S; Janweja M; Sengupta A
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
[TBL] [Abstract][Full Text] [Related]
14. Corneal manifestations and treatment among patients with COVID-19-associated rhino-orbito-cerebral mucormycosis.
Yadav R; Madan S; Rohatgi J; Sahu PK; Das S; Tandon A; Rai P; Verma P; Singh J; Bajaj I
Indian J Ophthalmol; 2023 Jan; 71(1):101-108. PubMed ID: 36588217
[TBL] [Abstract][Full Text] [Related]
15. Rhino-orbito-cerebral mucormycosis in a post-COVID-19 diabetic patient: Rare case from Iran.
Fakhar M; Sharifpour A; Zakariaei Z; Banimostafavi ES; Soleymani M; Davoodi L
Clin Case Rep; 2022 Feb; 10(2):e05506. PubMed ID: 35237439
[TBL] [Abstract][Full Text] [Related]
16. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
17. Diabetic versus non-diabetic rhino-orbito-cerebral mucormycosis.
Abdolalizadeh P; Kashkouli MB; Khademi B; Karimi N; Hamami P; Es'haghi A
Mycoses; 2020 Jun; 63(6):573-578. PubMed ID: 32191363
[TBL] [Abstract][Full Text] [Related]
18. Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis.
Manesh A; John AO; Mathew B; Varghese L; Rupa V; Zachariah A; Varghese GM
Mycoses; 2016 Dec; 59(12):765-772. PubMed ID: 27443253
[TBL] [Abstract][Full Text] [Related]
19. Rhino-orbito-cerebral mucormycosis: report of two cases and review of the literature.
Haliloglu NU; Yesilirmak Z; Erden A; Erden I
Dentomaxillofac Radiol; 2008 Mar; 37(3):161-6. PubMed ID: 18316508
[TBL] [Abstract][Full Text] [Related]
20. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
Yadav S; Bs N; Ak S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
